gabexate has been researched along with Liver Neoplasms in 8 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanuma, S | 1 |
| Tajima, H | 1 |
| Okamoto, K | 1 |
| Hayashi, H | 1 |
| Nakagawara, H | 1 |
| Onishi, I | 1 |
| Takamura, H | 1 |
| Kitagawa, H | 2 |
| Fushida, S | 1 |
| Tani, T | 1 |
| Fujimura, T | 1 |
| Kayahara, M | 2 |
| Ohta, T | 2 |
| Wakayama, T | 1 |
| Iseki, S | 1 |
| Harada, S | 1 |
| Yoon, WH | 1 |
| Jung, YJ | 1 |
| Kim, TD | 1 |
| Li, G | 1 |
| Park, BJ | 1 |
| Kim, JY | 1 |
| Lee, YC | 1 |
| Kim, JM | 1 |
| Park, JI | 1 |
| Park, HD | 1 |
| No, ZS | 1 |
| Lim, K | 1 |
| Hwang, BD | 1 |
| Kim, YS | 1 |
| Wada, Y | 1 |
| Zaima, M | 1 |
| Mori, K | 1 |
| Egawa, H | 1 |
| Higashiyama, H | 1 |
| Iwata, S | 1 |
| Kagawa, R | 1 |
| Kataoka, M | 1 |
| Ozawa, K | 1 |
| Matsuda, Y | 1 |
| Kawata, S | 1 |
| Nagase, T | 1 |
| Maeda, Y | 1 |
| Yamasaki, E | 1 |
| Kiso, S | 1 |
| Ishiguro, H | 1 |
| Matsuzawa, Y | 1 |
| Futagami, F | 1 |
| Arakawa, H | 1 |
| Tsukioka, Y | 1 |
| Nagakawa, T | 1 |
| Miyazaki, I | 1 |
| Ukai, K | 1 |
| Fuji, A | 1 |
| Nishiwaki, J | 1 |
| Yamada, T | 1 |
| Hotta, N | 1 |
| Kobayashi, Y | 1 |
| Kondo, C | 1 |
| Miyajima, K | 1 |
| Takada, T | 1 |
| Kinoshita, Y | 1 |
| Hanai, S | 1 |
| Tsuzuki, T | 1 |
| Toyama, K | 1 |
| Nakayasu, K | 1 |
| Iida, S | 1 |
| Ueda, M | 1 |
| Toizumi, A | 1 |
| Mikata, N | 1 |
| Imao, S | 1 |
| Tanaka, Y | 1 |
| Horiuchi, D | 1 |
| Matsumoto, G | 1 |
| Hasegawa, K | 1 |
1 review available for gabexate and Liver Neoplasms
| Article | Year |
|---|---|
[Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer].
Topics: Animals; Esters; Gabexate; Guanidines; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplan | 1996 |
2 trials available for gabexate and Liver Neoplasms
| Article | Year |
|---|---|
Effect of gabexate mesilate on thrombin and plasmin generation after hepatic resection in cirrhotic patients.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fibrinolysin; Gabexate; Hepatectomy; Humans; Liver Cirrhosi | 1995 |
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.
Topics: Aged; Aspartate Aminotransferases; C-Reactive Protein; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
5 other studies available for gabexate and Liver Neoplasms
| Article | Year |
|---|---|
Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocell | 2010 |
Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Topics: Animals; Capillaries; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Culture | 2004 |
Giant hepatic angiomyolipoma associated with disseminated intravascular coagulation.
Topics: Aged; Angiomyolipoma; Anticoagulants; Disseminated Intravascular Coagulation; Female; Fibrinolysis; | 1997 |
Disseminated intravascular coagulation after hepatic resection.
Topics: Anticoagulants; Bile Ducts; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Fibri | 1990 |
[A case of renal cancer complicated with acute hypercalcemia and acute pancreatitis].
Topics: Acute Disease; Calcitonin; Emergencies; Gabexate; Guanidines; Humans; Hypercalcemia; Kidney Neoplasm | 1989 |